4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-16-114857
Options or other derivatives
- Chief Medical Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Levy Howard · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-04-18 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +100,000 | $1.52 | 2026-04-18 | 100,000 | 100,000 | D |
Loading xslF345X03/doc4.xml…